These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2138718

  • 1. Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia.
    Ferrarese C, Appollonio I, Frigo M, Meregalli S, Piolti R, Tamma F, Frattola L.
    Neurology; 1990 Apr; 40(4):632-5. PubMed ID: 2138718
    [Abstract] [Full Text] [Related]

  • 2. Diazepam binding inhibitor-like immunoreactivity (DBI-LI) in human CSF. Correlations with neurological disorders.
    Ferrero P, Benna P, Costa P, Tarenzi L, Baggio G, Bergamasco B, Bergamini L.
    J Neurol Sci; 1988 Nov; 87(2-3):327-49. PubMed ID: 3210041
    [Abstract] [Full Text] [Related]

  • 3. Diazepam binding inhibitor in brain and in cerebrospinal fluid of human.
    Ferrero P, Penna P, Vischia F, Tarenzi L, Bergamasco B, Bergamini L.
    Ann Ist Super Sanita; 1988 Nov; 24(3):443-59. PubMed ID: 3190067
    [No Abstract] [Full Text] [Related]

  • 4. CSF somatostatin-like immunoreactivity in dementia.
    Beal MF, Growdon JH, Mazurek MF, Martin JB.
    Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
    [Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.
    Enna SJ, Stern LZ, Wastek GJ, Yamamura HI.
    Arch Neurol; 1977 Nov; 34(11):683-5. PubMed ID: 143928
    [Abstract] [Full Text] [Related]

  • 6. Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease.
    Barbaccia ML, Costa E, Ferrero P, Guidotti A, Roy A, Sunderland T, Pickar D, Paul SM, Goodwin FK.
    Arch Gen Psychiatry; 1986 Dec; 43(12):1143-7. PubMed ID: 3022663
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases.
    Claus JJ, Mohr E.
    Acta Neurol Scand; 1996 May; 93(5):346-51. PubMed ID: 8800345
    [Abstract] [Full Text] [Related]

  • 10. Hypocretin-1 (orexin A) levels are normal in Huntington's disease.
    Baumann CR, Hersberger M, Bassetti CL.
    J Neurol; 2006 Sep; 253(9):1232-3. PubMed ID: 16598614
    [No Abstract] [Full Text] [Related]

  • 11. Demonstration of CSF gamma-globulin banding in presenile dementia.
    Williams A, Papadopoulos N, Chase TN.
    Neurology; 1980 Aug; 30(8):882-4. PubMed ID: 6158020
    [Abstract] [Full Text] [Related]

  • 12. Acetylcholine and choline in cerebrospinal fluid of patients with Parkinson's disease and Huntington's chorea.
    Welch MJ, Markham CH, Jenden DJ.
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):367-74. PubMed ID: 132512
    [Abstract] [Full Text] [Related]

  • 13. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
    Pillon B, Dubois B, Ploska A, Agid Y.
    Neurology; 1991 May; 41(5):634-43. PubMed ID: 1827513
    [Abstract] [Full Text] [Related]

  • 14. Confrontation naming impairment in dementia.
    Bayles KA, Tomoeda CK.
    Brain Lang; 1983 May; 19(1):98-114. PubMed ID: 6222782
    [Abstract] [Full Text] [Related]

  • 15. Parkinson's disease. The possible relationship of laterality to dementia and neurochemical findings.
    Direnfeld LK, Albert ML, Volicer L, Langlais PJ, Marquis J, Kaplan E.
    Arch Neurol; 1984 Sep; 41(9):935-41. PubMed ID: 6477229
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.
    Biol Psychiatry; 2008 Nov 15; 64(10):850-5. PubMed ID: 18395699
    [Abstract] [Full Text] [Related]

  • 18. Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor.
    White LR, Gårseth M, Aasly J, Sonnewald U.
    J Neurosci Res; 2004 Oct 15; 78(2):297-301. PubMed ID: 15378514
    [Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy.
    Zubenko GS, Volicer L, Direnfeld LK, Freeman M, Langlais PJ, Nixon RA.
    Brain Res; 1985 Mar 04; 328(2):215-21. PubMed ID: 2985183
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.